Cuts proposed by the Trump administration and House Republicans could drive up new HIV cases by more than 200,000 by 2030, ...

Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...

October is National Substance Abuse Prevention Month, an opportunity to recognize the impact of substance use in the U.S. and ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Oct. 10, 2025, is officially the first-ever National PrEP Day, and MISTR and SISTR are going big. Their goal? Get 10,000 new ...

Global health groups will provide backing for two generic manufacturers to produce and distribute a low-cost version of a new ...

The Food and Drug Administration has approved Yeztugo, a revolutionary HIV prevention injection that represents the most significant advancement in HIV prevention strategies in more than four decades.

Learn about the unique health and social needs of HIV-infected senior Americans. Health experts emphasize the importance of prevention, testing, and care.

Gilead has agreed to provide the drug at cost and to share its intellectual property with generic manufacturers who can ...

In June, the US Food and Drug Administration approved a new drug that could transform HIV prevention. People at risk of HIV can get an injection of lenacapavir every six months and be almost ...